Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate PROCEPT BioRobotics Corporation before investing.

In this article, we go over a few key elements for understanding PROCEPT BioRobotics Corporation’s stock price such as:

• PROCEPT BioRobotics Corporation’s current stock price and volume
• Why PROCEPT BioRobotics Corporation’s stock price changed recently
• Upgrades and downgrades for PRCT from analysts
• PRCT’s stock price momentum as measured by its relative strength

About PROCEPT BioRobotics Corporation (PRCT)

Before we jump into PROCEPT BioRobotics Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Want to learn more about PROCEPT BioRobotics Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about PROCEPT BioRobotics Corporation.

What Caused PROCEPT BioRobotics Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 01, 2026, there were 2 analysts who downgraded PROCEPT BioRobotics Corporation’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate PROCEPT BioRobotics Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on PROCEPT BioRobotics Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

PROCEPT BioRobotics Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about PROCEPT BioRobotics Corporation (PRCT) by visiting AAII Stock Evaluator.

Relative Price Strength of PROCEPT BioRobotics Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 01, 2026, PROCEPT BioRobotics Corporation has a weighted four-quarter relative price strength of -21.20%, which translates to a Momentum Score of 9 and is considered to be Very Weak.

Want to learn more about how PROCEPT BioRobotics Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

PROCEPT BioRobotics Corporation Stock Price: Bottom Line

As of May 1, 2026, PROCEPT BioRobotics Corporation’s stock price is $24.630, which is up 2.45% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like PROCEPT BioRobotics Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.